Einstein-Mount Sinai Diabetes Research Center

试点和可行性研究(P&F)计划的任务是为新的调查人员提供初步支持， 老牌研究人员探索新方向，并使爱因斯坦-西奈山糖尿病研究 中心(ES-DRC)吸引其他学科的科学家参与糖尿病研究。P&F计划是一个至关重要的 Es-DRC的组成部分，并成功地促进了许多糖尿病的新研究努力- 相关领域。这一计划构成了爱因斯坦、西奈山和其他地区之间的关键接口 在整个学术界，并作为招聘教职员工的一个主要吸引力。完毕 在过去的37年里，该中心从449项申请中资助了113项可行性研究(资金率 25.1%)。这些研究还包括本项目期间为增加申请数量所作的有针对性的努力。 由我们的区域中心在基础、临床和转化性糖尿病方面提供资金。我们预计会有资金 7个稳定状态的试点和可行性拨款，在4个新奖项和3个持续奖项之间轮换，每个奖项 第一年；通常情况下，如果第一年之后显示出足够的进展，则为项目提供两年的资金。P&F 研究计划使接受者能够获得构成成功的基础的数据和出版物 申请校外支持。在与试点和可行性计划相同的管理框架下， 我们建立了一个小额赠款奖励计划，为ES-DRC核心的使用提供具体支持 设施。去年，小额赠款计划资助了19个提交的申请中的8个奖项。此外，我们 还与爱因斯坦临床和翻译科学奖合作提供催化种子赠款，以支持 糖尿病专属翻译研究。这些增值计划进一步加强了针对糖尿病的 研究努力。为了在P&F计划中继续这些既定的和新的计划，我们将：1) 宣传和组织一年一度的P&F赠款竞赛周期；2)支持互动和 糖尿病及相关领域的老牌研究人员和新手之间的合作 3)为糖尿病研究新手提供指导和指导，以促进 生成初步数据，目标是成功申请国立卫生研究院的资金和其他资金 来源；4)通过将P&F获奖者整合到ES-DRC，向他们传达责任和机会 活动；5)提供10,000美元的免费使用每个ES-DRC直接与 资助的P&F项目；以及6)管理机构小额赠款和催化种子赠款计划 糖尿病和新陈代谢。

The mission of the Pilot & Feasibility Study (P&F) Program is to provide initial support for new investigators, for established investigators to explore new directions, and to enable the Einstein-Mount Sinai Diabetes Research Center (ES-DRC) to attract scientists from other disciplines to diabetes research. The P&F Program is a vital component of the ES-DRC and has successfully promoted numerous new research endeavors in diabetes- related areas. This program constitutes a key interface among the Einstein, Mount Sinai and other regional academic communities at large, and serves as a major attraction in the recruitment of faculty and staff. Over the past 37 years the Center funded 113 feasibility studies from a pool of 449 applications (funding rate of 25.1%). These studies also include targeted efforts in this project period to increase the number of applications funded in our regional center at both the basic, clinical and translational diabetes efforts. We anticipate funding 7 Pilot & Feasibility grants at steady state, alternating between 4 new awards and 3 continuing awards, each year; typically, projects are funded for two years if sufficient progress is shown after the first year. The P&F study program has enabled recipients to obtain data and publications that constituted the basis for successful applications for extramural support. Under the same administrative umbrella as the Pilot & Feasibility program, we established a microgrant award program that provides specific support for the use of ES-DRC Core facilities. Last year, the microgrant program funded 8 awards out of 19 submitted applications. In addition, we also partner with the Einstein Clinical and Translational Science Award on a catalytic seed grant to support diabetes-specific translation research. These value added programs further enhance diabetes directed research efforts. To continue these established and new initiatives within the P&F program, we will: 1) advertise and organize the yearly P&F grant competition cycle; 2) support mechanisms for interaction and collaboration among established researchers in diabetes and related areas and for those who are new to the field; 3) provide mentoring and guidance for investigators who are new to diabetes research to facilitate generation of preliminary data with the goal of successful applications for NIH funding and other funding sources; 4) communicate responsibilities and opportunities to P&F awardees by integrating them into ES-DRC activities; 5) provide $10,000 of free use of each ES-DRC Biomedical Core services directly related to the funded P&F project; and 6) manage the institutionally microgrant and Catalytic Seed Grant Award programs in diabetes and metabolism.